Drug Development Health Information Industry 
Society for Participatory Medicine
FEBRUARY 1, 2023
By the power vested in clinical research, the FDA now pronounces us patient and industry. The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. I’m here to deliver some great news: we tied the knot!
Lloyd Price
OCTOBER 28, 2024
Exec Summary: The healthtech industry, while brimming with potential, faces several significant challenges that hinder its full potential. Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
DECEMBER 2, 2024
However, based on current trends and industry insights, several areas are poised for significant growth and increased valuations: 1. Companies specialising in AI-driven medical imaging, drug development, and predictive analytics are likely to see substantial valuation increases.
Healthcare IT Today
JANUARY 8, 2024
The excitement around new tools took hold of all industries in 2023, and the potential is expansive. The unification of technology, services and pharmacovigilance expertise in the coming year will further enunciate the industry’s focus on patient safety. Dave Latshaw, CEO at BioPhy 1.
Lloyd Price
JANUARY 20, 2025
Data Privacy and Security: Ensuring the privacy and security of consumer data is crucial, especially when dealing with sensitive health information. Data-Driven Insights: B2C2B models generate a wealth of data that can be leveraged to refine products, identify new opportunities, and inform business decisions.
Lloyd Price
NOVEMBER 8, 2024
Several key trends and predictions are emerging: Increased focus on digital health and AI: AI-powered diagnostics and drug discovery: Companies specialising in AI-driven medical imaging, genomics analysis, and drug development are likely to attract significant interest from larger pharmaceutical and technology firms.
Lloyd Price
MAY 18, 2021
Desperate for medical insights without delay, researchers, pharmaceutical companies and government agencies turned to health information captured through real-world data sources. A new medication is introduced to the market via legislation rather than through formal drug development practices (3); 3.
Expert insights. Personalized for you.
112 
Let's personalize your content